Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia.
Tarlock K et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2019